These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10342662)

  • 41. [Lipoprotein lipase-mediated myopathy: implications for lipid metabolism and atherogenesis].
    Merkel M; Radner H; Greten H
    Med Klin (Munich); 2003 Dec; 98(12):679-84. PubMed ID: 14685668
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of oxidative modifications in atherosclerosis.
    Stocker R; Keaney JF
    Physiol Rev; 2004 Oct; 84(4):1381-478. PubMed ID: 15383655
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The paediatric origins of atherosclerosis.
    Evans GR; Taylor KG
    Br J Hosp Med; 1988 Feb; 39(2):132-7. PubMed ID: 3359081
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Blood histamine is associated with coronary artery disease, cardiac events and severity of inflammation and atherosclerosis.
    Clejan S; Japa S; Clemetson C; Hasabnis SS; David O; Talano JV
    J Cell Mol Med; 2002; 6(4):583-92. PubMed ID: 12611642
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is sudden death with vitamin C deficiency caused by lack of carnitine?
    Okamoto M; Ueno Y
    J Clin Forensic Med; 2006 Jan; 13(1):26-9. PubMed ID: 16084747
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care.
    Booth GL; Wang EE
    CMAJ; 2000 Jul; 163(1):21-9. PubMed ID: 10920726
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Leukocyte-endothelial cell interactions and vascular injury in the earliest preclinical stages of atherosclerosis.
    Lombardini R; Vaudo G; Ciuffetti G
    Haematologica; 1997; 82(2):253. PubMed ID: 9175334
    [No Abstract]   [Full Text] [Related]  

  • 48. [Is treatment of metabolic factors a valid method in the control of arteriosclerosis and coronary disease?].
    Avogaro P
    Clin Ter; 1984 Oct; 111(1):15-9. PubMed ID: 6238776
    [No Abstract]   [Full Text] [Related]  

  • 49. If a child is at risk for heart disease.
    Cerrato PL
    RN; 1988 Oct; 51(10):93-4. PubMed ID: 3206122
    [No Abstract]   [Full Text] [Related]  

  • 50. [Current problems in the etiopathogenesis of atherosclerosis].
    Creţeanu G; Mungiu OC; Hurjui J; Creţeanu M; Creţeanu G
    Rev Med Chir Soc Med Nat Iasi; 1985; 89(1):109-12. PubMed ID: 4070862
    [No Abstract]   [Full Text] [Related]  

  • 51. Leukocyte ascorbic acid and its relationship to coronary artery disease in man.
    Ramirez J; Flowers NC
    Am J Clin Nutr; 1980 Oct; 33(10):2079-87. PubMed ID: 7424804
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hyperglycemia-induced ascorbic acid deficiency promotes endothelial dysfunction and the development of atherosclerosis.
    Price KD; Price CS; Reynolds RD
    Atherosclerosis; 2001 Sep; 158(1):1-12. PubMed ID: 11500168
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Premature peripheral atherosclerosis.
    Valentine RJ
    Cardiovasc Surg; 1993 Oct; 1(5):473-80. PubMed ID: 8076080
    [No Abstract]   [Full Text] [Related]  

  • 54. [Clinical study of children and adolescents with risk factors for atherosclerosis and ischemic heart disease].
    Visokinskene GI; Grinkiavichene OK; Gerulene GA; Ostrauskene SV
    Pediatriia; 1984 Nov; (11):6-8. PubMed ID: 6527916
    [No Abstract]   [Full Text] [Related]  

  • 55. Coronary disease and atherosclerosis risk factors--can we alter the course of the disease?
    Weaver WF
    Nebr Med J; 1980 Aug; 65(8):229-32. PubMed ID: 7402406
    [No Abstract]   [Full Text] [Related]  

  • 56. [Current cellular aspects of atherosclerosis. Risk factors in its etiology and treatment].
    Schettler G
    Wien Med Wochenschr; 1990; 140(21):530-1. PubMed ID: 2275208
    [No Abstract]   [Full Text] [Related]  

  • 57. [Certain indicators of liver function and histamine metabolism in patients with coronary atherosclerosis].
    Shustval' NF
    Vrach Delo; 1974 Feb; (2):63-7. PubMed ID: 4143229
    [No Abstract]   [Full Text] [Related]  

  • 58. [Triglycerides and atherosclerosis: update and therapeutic recommendations].
    Hussein O; Traub YM
    Harefuah; 1994 May; 126(10):593-7. PubMed ID: 8034250
    [No Abstract]   [Full Text] [Related]  

  • 59. Reducing cholesterol and atherosclerosis.
    Hornung RS
    QJM; 2002 Jun; 95(6):339-41. PubMed ID: 12037241
    [No Abstract]   [Full Text] [Related]  

  • 60. [The role of transmural permeability defects in the pathomechanism of arteriosclerosis. I. Theories on arteriosclerosis and transmural permeability].
    Detre Z; Jellinek H
    Morphol Igazsagugyi Orv Sz; 1985 Apr; 25(2):81-6. PubMed ID: 4010687
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.